Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can ECT-induced cognitive effects be altered pharmacologically?

A Khan1, M H Mirolo, H A Mirolo

  • 1Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|November 1, 1993
PubMed
Summary

This review found no conclusive evidence for drugs treating electroconvulsive therapy (ECT)-induced cognitive deficits. Future research should focus on the underlying neural mechanisms of these cognitive changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
Same author

Measurement of CP-violating asymmetries in B0 decays to CP eigenstates.

Physical review letters·2001
Same author

The placebo enigma in antidepressant clinical trials.

Journal of clinical psychopharmacology·2001
Same author

Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.

Diabetes·2001
Same author

Hyperglycemia contributes to impaired insulin response in GK rat islets.

Diabetes·2001
Same author

O2 dependence of K+ transport in sickle cells: the effect of different cell populations and the substituted benzaldehyde 12C79.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Pharmacology

Background:

  • Electroconvulsive therapy (ECT) can cause cognitive deficits.
  • Existing treatments aim to prevent, restore, or manage these deficits.
  • The clinical utility of pharmacological interventions remains unclear.

Purpose of the Study:

  • To systematically review the literature on drugs used to manage ECT-induced cognitive deficits.
  • To evaluate the effectiveness and clinical utility of these interventions.
  • To identify gaps in current research and suggest future directions.

Main Methods:

  • Systematic literature review of clinical trials.
  • Analysis of twelve trials evaluating nine different drugs.
  • Examination of three distinct conceptual models for cognitive deficits.

Related Experiment Videos

Main Results:

  • Inconclusive results regarding the clinical utility of evaluated drugs.
  • Complexities in evaluating ECT-induced cognitive deficits were identified.
  • Challenges in assessing cognitive function changes were discussed.

Conclusions:

  • Current pharmacological interventions lack proven clinical utility for ECT-induced cognitive deficits.
  • Further research is needed to understand the neural mechanisms underlying these deficits.
  • Exploration of novel therapeutic targets and strategies is recommended.